Catalent
CTLT
#1499
Rank
NZ$19.84 B
Marketcap
$109.31
Share price
0.00%
Change (1 day)
16.96%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -$2.09

According to Catalent's latest financial reports the company's current EPS (TTM) is -$2.22. In 2022 the company made an earnings per share (EPS) of $3.91 a decrease over its 2021 EPS that were of $5.63.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.09-153.52%
2022$3.91-30.58%
2021$5.6379.67%
2020$3.13114.12%
2019$1.46-15%
2018$1.7275.44%
2017$0.98-22.97%
2016$1.27-59.56%
2015$3.15282.05%
2014$0.82-378.2%
2013-$0.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.36-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.29-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.43 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.00-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA